Literature DB >> 12542560

Association between vitamin D receptor gene polymorphisms and tubular citrate handling in calcium nephrolithiasis.

G Mossetti1, P Vuotto, D Rendina, F G Numis, R Viceconti, F Giordano, M Cioffi, F Scopacasa, V Nunziata.   

Abstract

OBJECTIVES: Hypocitraturia is a risk factor for calcium nephrolithiasis. 1,25(OH)2D3 influences renal citrate handling and enhances citraturia. The aim of this study was to evaluate the relationship between vitamin D receptor (VDR) allelic variant and urinary citrate excretion in recurrent stone formers (SF) patients.
DESIGN: Case-control study.
SUBJECTS: A total of 220 recurrent calcium oxalate SF patients and 114 healthy control (C) subjects were enrolled for this study. Subjects with urinary tract infections, hyperparathyroidism, cystinuria >70 micromol/24 h, gouty diathesis, renal tubular acidosis, renal failure, chronic diarrhoeal states, intake of thiazide diuretics, angiotensin-converting enzyme (ACE)-inhibitors, glucocorticoids or oestrogens were excluded. A standard constant diet was given for 7 days. The 24-h urinary citrate excretion and the active tubular reabsorption of filtered citrate (Rcit) were evaluated. Hypocitraturia was defined as a urinary citrate excretion lower than 1.7 mmol day-1. Stone formers patients and C were genotyped for BsmI and TaqI VDR alleles. Contingency table chi-square tests were used to compare genotype frequencies in hypocitraturic SF patients, normocitraturic SF and C.
RESULTS: The prevalence of hypocitraturia in SF patients was 32.7% (72 of 200). Hypocitraturia in these patients resulted from excessive Rcit of a normal load of citrate. We found a different distribution (P < 0.05) of BsmI and TaqI VDR genotypes in hypocitraturic SF patients compared with normocitraturic SF and C. In particular, the prevalence of bb and TT VDR genotypes in hypocitraturic SF was significantly higher than in normocitraturic SF and C.
CONCLUSIONS: These results point to a genetic association between BsmI and TaqI VDR polymorphisms and idiopathic hypocitraturia in calcium-oxalate recurrent SF patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12542560     DOI: 10.1046/j.1365-2796.2003.01086.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  24 in total

1.  Update on the genetics of nephrolithiasis.

Authors:  Giuseppe Vezzoli; Teresa Arcidiacono; Vera Paloschi; Annalisa Terranegra; Rita Biasion; Laura Soldati
Journal:  Clin Cases Miner Bone Metab       Date:  2008-05

2.  ApaL1 urokinase and Taq1 vitamin D receptor gene polymorphisms in first-stone formers, recurrent stone formers, and controls in a Caucasian population.

Authors:  Serdar Aykan; Murat Tuken; Sezgin Gunes; Yigit Akin; Murat Ozturk; Serkan Seyhan; Emrah Yuruk; Mustafa Zafer Temiz; Ali Faik Yılmaz; Daniel P Nguyen
Journal:  Urolithiasis       Date:  2015-08-15       Impact factor: 3.436

3.  Vitamin D receptor gene polymorphisms in patients with urolithiasis.

Authors:  Sezgin Gunes; Cenk Yucel Bilen; Nurten Kara; Ramazan Asci; Hasan Bagci; Ali Faik Yilmaz
Journal:  Urol Res       Date:  2006-01-06

4.  Evidence for epistatic interaction between VDR and SLC13A2 genes in the pathogenesis of hypocitraturia in recurrent calcium oxalate stone formers.

Authors:  Domenico Rendina; Gianpaolo De Filippo; Fernando Gianfrancesco; Riccardo Muscariello; Michele Schiano di Cola; Pasquale Strazzullo; Teresa Esposito
Journal:  J Nephrol       Date:  2016-09-17       Impact factor: 3.902

5.  Association of vitamin D receptor gene polymorphism and calcium urolithiasis in the Chinese Han population.

Authors:  Shuai Wang; Xiao Wang; Jian Wu; Yiwei Lin; Hong Chen; Xiangyi Zheng; Cheng Zhou; Liping Xie
Journal:  Urol Res       Date:  2011-11-25

6.  Educational review: role of the pediatric nephrologists in the work-up and management of kidney stones.

Authors:  Carmen Inés Rodriguez Cuellar; Peter Zhan Tao Wang; Michael Freundlich; Guido Filler
Journal:  Pediatr Nephrol       Date:  2019-01-04       Impact factor: 3.714

7.  Renal expression and urinary excretion of Na+/dicarboxylate cotransporter 1 (NaDC1) in obstructive nephropathy: a candidate biomarker for this pathology.

Authors:  Romina V Campagno; María J Severin; Evangelina C Nosetto; Anabel Brandoni; Adriana Mónica Torres
Journal:  Pflugers Arch       Date:  2018-08-23       Impact factor: 3.657

8.  Proton-pump inhibitors associated with decreased urinary citrate excretion.

Authors:  Parth M Patel; Alexander M Kandabarow; Eseosa Aiwerioghene; Enrique Blanco-Martinez; Spencer Hart; David J Leehey; Ahmer Farooq; Kristin G Baldea; Thomas M T Turk
Journal:  Int Urol Nephrol       Date:  2020-11-18       Impact factor: 2.370

9.  Vitamin D receptor gene (VDR) polymorphisms and the urolithiasis risk: an updated meta-analysis based on 20 case-control studies.

Authors:  Wentao Liu; Minfeng Chen; Mengjun Li; Hong Ma; Shiyu Tong; Ye Lei; Lin Qi
Journal:  Urolithiasis       Date:  2013-11-05       Impact factor: 3.436

10.  Increased biological response to 1,25(OH)(2)D(3) in genetic hypercalciuric stone-forming rats.

Authors:  Kevin K Frick; John R Asplin; Murray J Favus; Christopher Culbertson; Nancy S Krieger; David A Bushinsky
Journal:  Am J Physiol Renal Physiol       Date:  2013-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.